Functional imaging of Langerhans cell histiocytosis by 111In‐DTPA‐D‐Phe1‐octreotide scintigraphy
Open Access
- 31 January 2002
- Vol. 94 (3) , 633-640
- https://doi.org/10.1002/cncr.10276
Abstract
BACKGROUND: Langerhans cell histiocytosis is a rare group of diseases of unknown pathogenesis, variable clinical presentation, and behavior. It encompasses highly aggressive, often fatal, and indolent diseases, with a variety of intermediate forms between the two extremes. Localization and monitoring of Langerhans cell histiocytosis deposits are based on the combined use of different imaging modalities, which include magnetic resonance, computed tomography, and nuclear medicine procedures. Somatostatin receptor scintigraphy recently has been used to image immune‐mediated diseases with excellent results.METHODS: In this study, the authors have evaluated the potential role of somatostatin receptor scintigraphy by using 111In‐DTPA‐D‐Phe1‐octreotide in a series of patients with Langerhans cell histiocytosis. Eight consecutive patients (2 males, 6 females; mean age, 43 years; age range, 29–60 years) with histologically proven Langerhans cell histiocytosis, in various phases of their disease, were imaged 24 hours after intravenous injection of 111–222 MBq of 111In‐DTPA‐D‐Phe1‐octreotide, by using total body and spot view images. The objective of the study was to preliminarly evaluate this technique in the evaluation of Langerhans cell histiocytosis.RESULTS: Most Langerhans cell histiocytosis deposits were clearly documented by somatostatin receptor scintigraphy, independently from the anatomic location (i.e., skeleton, mucosae, soft tissue, etc.). The correlation between conventional imaging modalities and somatostatin receptor scintigraphy results was fairly good, though this was not considered a primary objective of the study.CONCLUSIONS: Among the various imaging modalities for Langerhans cell histiocytosis, somatostatin receptor scintigraphy is unique, becuase it accurately depicts the active sites of disease and thus can help in monitoring the response to treatment, together with conventional imaging modalities. Further studies are necessary to confirm the diagnostic value of this technique and clarify the biologic significance of the expression of somatostatin receptors in Langerhans cell histiocytosis. Cancer 2002;94:633–40. © 2002 American Cancer Society.DOI 10.1002/cncr.10276Keywords
This publication has 28 references indexed in Scilit:
- Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomasEuropean Journal of Clinical Investigation, 1999
- Thickened Pituitary Stalk on Magnetic Resonance Imaging in Children with Central Diabetes InsipidusJournal of Clinical Endocrinology & Metabolism, 1999
- Orbital Scintigraphy with [111In-Diethylenetriamine Pentaacetic Acid-D-Phe1]-Octreotide Predicts the Clinical Response to Corticosteroid Therapy in Patients with Graves' OphthalmopathyJournal of Clinical Endocrinology & Metabolism, 1998
- Thallium-201 uptake in Langerhans cell histiocytosis of bonePediatric Radiology, 1996
- Detection of Bone Lesions in Langerhans Cell HistiocytosisJournal of Pediatric Hematology/Oncology, 1996
- Pituitary stalk thickening with diabetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in childrenEuropean Journal of Pediatrics, 1993
- Somatostatin analogue scintigraphy of malignant lymphomasBritish Journal of Haematology, 1993
- Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with langerhans cell histiocytosis and diabetes insipidusMedical and Pediatric Oncology, 1993
- Magnetic resonance imaging in patients with hypopituitarismTrends in Endocrinology & Metabolism, 1992
- Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.Journal of Clinical Investigation, 1990